The Caisse de dépôt et placement du Québec is investing 200 million euros in Eurofins Scientific, a global laboratory testing services company.
Caisse describes the company’s strategic acquisitions and “sustained organic growth” as motivation for the investment, adding that it hopes to continue to make acquisitions in Eurofins’ industry, which it calls “highly fragmented.”
Read: Caisse announces organizational shakeup
“Eurofins has successfully established itself as a world leader in the cutting-edge market segment of bio-analysis testing,” said Roland Lescure, executive vice-president and chief investment officer at Caisse. “CDPQ will support Eurofins’ management team as it pursues its international growth plans.“
“This transaction provides Eurofins with the ability to potentially accelerate the achievement of its mid-term plan, should the opportunity arise, and create significant incremental shareholder value with limited dilution,” added Dr. Gilles Martin, chief executive officer of Eurofins Scientific.
Read: Caisse acquires 44% stake in Australian insurance distributor